我们的网站为什么显示成这样?

可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:

|本期目录/Table of Contents|

机械瓣膜置换术后孕期抗凝策略的研究进展

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2014年第1期
页码:
104-107
栏目:
综述
出版日期:
2013-12-02

文章信息/Info

Title:
Postoperative anticoagulation therapy for pregnant women after mechanic valve replacement surgery
作者:
徐志懿1关新强1曹 烨1高秉仁2
(兰州大学:1.第二临床院医学院,2.第二附属医院心外一科,甘肃 兰州 730000)
Author(s):
XU Zhi-yi1 GUAN Xin-qiang1 CAO Ye1 GAO Bing-ren2
(1.Second Clinic College, 2.First Department of Cardiac Surgery, Second Affiliated Hospital, Lanzhou University, Lanzhou 730000, Gansu, China)
关键词:
机械瓣膜置换术抗凝策略孕妇
Keywords:
mechanical valvular replacement surgery anticoagulation strategy pregnant woman
分类号:
R973.2
DOI:
-
文献标识码:
A
摘要:
机械瓣置换术(MVRS)是一项广泛开展的心脏手术,接受该手术的患者中,孕妇是较为特殊的群体。首选抗凝药物华法林可增加胎儿的毁损率,而替代的肝素类药品虽未减小胎儿的毁损,但可明显增加致死性血栓栓塞的发生。寄予厚望的新药达比加群酯并不能很好地预防机械瓣形成血栓,而利伐沙班及阿哌沙班的抗血栓形成效果并不比旧药表现出色,其对胎儿的副作用尚未有详细的实验室或临床证据。本文就以上问题进行了详述。
Abstract:
Mechanical valvular replacement surgeries represent highly operated cardiac surgeries globally. In patients who receive replacement surgeries, postoperative anticoagulation therapy for pregnant women requires special attention. Administration of warfarin, the most common anticoagulant after surgery, increases fetal damage. Instead of decreasing fetal damage, heparins used as replacement drugs dramatically increase the rate of embolism. Of the new drugs, dabigatran is confirmed to exert a poor effect in preventing thrombus from mechanical heart valves. Rivaroxaban and apixaban have achieved no better results in thrombogenesis. No clinical or experimental findings have been reported about the side effects of these new drugs to fetuses. This paper will review the research progress of the prescribed drugs in thrombus prevention.

参考文献/References

[1]董 力,刘兴会,石应康.心脏机械瓣膜置换术后妊娠妇女低强度华法林抗凝治疗56例[J].中华胸心血管外科杂志, 2011,27(1): 8-10.
[2]李 杰,刘国勋,凌光鑫,等.血浆D二聚体动态监测对知道换瓣术后抗凝治疗的临床意义[J].广东医学院学报,1996,14(2):103-104.
[3]Wesseling J,Van Driel D,Heymans HS,et al.Coumarins during pregnancy:long-term effects on growth and development of school-age children[J].Thromb Haemost,2001,85(4):609-613.
[4]葛蓓蕾,田陆云,王 红.华法林个体化用药的研究进展[J].中国老年学杂志,2012,32(10):2201-2204.
[5]喻杰峰,胡建国,周新民,等.心瓣膜置换术后孕产妇抗凝治疗(附183例临床报道)[J].中国现代医学杂志,2009(11):1713-1715.
[6]李 涛,赖 怡,边 策,等.机械心脏瓣膜置换术后孕早期肝素替代华法林抗凝治疗对妊娠结局影响的Meta分析[J].中国循证医学杂志,2008,8(1):42-46.
[7]Oran B,Lee-Parritz A,Ansell J.Low molecular weight heparin for the prophylaxis of thromboembolism in women with prosthetic mechanical heart valves during pregnancy[J].Thromb Haemost,2004,92(4):747-751.
[8]Van de Werf F,Brueckmann M,Connolly SJ,et al.A comparison of dabigatran etexilate with warfarin in patients with mechanical heart valves: THE Randomized, phase II study to evaluate the safety and pharmacokinetics of oral dabigatran etexilate in patients after heart valve replacement(RE-ALIGN)[J].Am Heart J,2012,163(6):931-937,e1.
[9]Kaeberich A,Reindl I,Raaz U,et al.Comparison of unfractionated heparin, low-molecular-weight heparin, low-dose and high-dose rivaroxaban in preventing thrombus formation on mechanical heart valves: results of an in vitro study[J].J Thromb Thrombolysis,2011,32(4):417-425.
[10]田国祥,魏万林,张 灵,等.后华法林时代口服抗凝新秀:达比加群、利伐沙班、阿哌沙班[J].中国循证心血管医学,2011,03(5):403-406.

备注/Memo

备注/Memo:
收稿日期:2013-06-15.通讯作者:高秉仁,主任医师,主要从事先心病,瓣膜病研究 Email:bingrengao@sina.com 作者简介:徐志懿,本科生Email:daisyxuzhiyi@gmail.com
更新日期/Last Update: 2014-01-20